title: Conventional dogma applied to quinolones? Time for a change.
authors.forename: R N
authors.initials: RN
authors.lastname: Jones
mesh_terms: D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001372:Aza Compounds; D002986:Clinical Trials as Topic; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D006801:Humans; D000077266:Moxifloxacin; D017063:Outcome Assessment, Health Care; D011008:Pneumococcal Infections / Q000188:drug therapy*; D011804:Quinolines; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D013296:Streptococcus pneumoniae / Q000187:drug effects
chemical_list: D042462:4-Quinolones; D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077734:Gatifloxacin; D000077266:Moxifloxacin